Australia markets closed

ImpediMed Limited (IPD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.05900.0000 (0.00%)
At close: 03:56PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 101.78M
Enterprise value 76.91M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.44
Price/book (mrq)2.50
Enterprise value/revenue 7.03
Enterprise value/EBITDA -3.62

Trading information

Stock price history

Beta (5Y monthly) 2.69
52-week change 3-61.94%
S&P500 52-week change 3-13.08%
52-week high 30.1550
52-week low 30.0490
50-day moving average 30.0613
200-day moving average 30.0707

Share statistics

Avg vol (3-month) 3635.26k
Avg vol (10-day) 3421.11k
Shares outstanding 51.79B
Implied shares outstanding 6N/A
Float 81.55B
% held by insiders 113.80%
% held by institutions 114.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -197.45%
Operating margin (ttm)-214.76%

Management effectiveness

Return on assets (ttm)-25.58%
Return on equity (ttm)-43.70%

Income statement

Revenue (ttm)11.03M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)8.80%
Gross profit (ttm)9.16M
EBITDA -22.68M
Net income avi to common (ttm)-21.7M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.2M
Total cash per share (mrq)0.01
Total debt (mrq)1.33M
Total debt/equity (mrq)3.26
Current ratio (mrq)5.47
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-21.57M
Levered free cash flow (ttm)-18.15M